DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Skelaxin (Metaxalone) - Adverse Event Reports - Serious Event - Confusional State

 



Index of reports > Cases resulting in a serious event (21) > Cases with Confusional State (4)

Below is the selection of adverse event reports related to Skelaxin (Metaxalone) that includes cases resulting in a serious event where reactions include confusional state.

Adverse event in 35 year old male receiving Skelaxin (Metaxalone)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-23

Patient: 35 year old male

Adverse reactions / side effects: Alcohol USE, Confusional State, Overdose, Cyanosis, Drug Level Increased, Aphasia, Abasia, Respiratory Arrest, Gait Disturbance, Fall, Feeling Cold

Adverse event resulted in: death

Suspect drug(s):
Fentanyl Transdermal System
    Dosage: 75 ug/hr; every 3 days; transdermal
    Indication: Back Pain
    Start date: 2006-01-30
    End date: 2006-02-04

Robaxin
    Dosage: ; every 4 hours; oral
    Administration route: Oral
    Indication: Back Pain

Oxycodone (10 MG)
    Dosage: 20 mg; every 4 hours; oral
    Administration route: Oral
    Indication: Back Pain

Skelaxin
    Dosage: 800 mg; 3 times a day; oral
    Administration route: Oral
    Indication: Back Pain

Alcohol / 00002101 /

Other drugs received by patient: Percocet; Lexapro; Ibuprofen; Multivitamin; Calcium / 00009901 /



Adverse event in receiving Skelaxin (Metaxalone)

Reported by a physician from United States on 2007-05-17

Patient:

Adverse reactions / side effects: Confusional State, Drug Toxicity, Drug Interaction, Troponin Increased

Adverse event resulted in: hospitalization

Suspect drug(s):
Skelaxin (Metaxalone)

Other drugs received by patient possibly interacting with the suspect drug:
Trazodone HCL
    End date: 2007-04-01

Opana
    End date: 2007-04-01

Opana ER
    End date: 2007-04-01

Vistaril / 00058402 /
    End date: 2007-04-01

Other drugs received by patient: Ambien; Quinine Sulfate; Sinemet; Januvia; Amaryl; Insulin; Ultram



Adverse event in female receiving Skelaxin (Metaxalone)

Reported by a consumer/non-health professional from United States on 2007-05-16

Patient: female, weighing 128.8 kg (283.4 pounds)

Adverse reactions / side effects: Confusional State, Drug Interaction, Narcotic Intoxication, Troponin Increased

Adverse event resulted in: hospitalization

Suspect drug(s):
Oxymorphone
    End date: 2007-04-01

Skelaxin

Trazodone HCL

Other drugs received by patient possibly interacting with the suspect drug:
Vistaril CAP

Other drugs received by patient: Ambien; Quinine Sulfate; Sinemet; ALL Other Therapeutic Products; Amaryl; Insulin; Ultram



Adverse event in 58 year old female receiving Skelaxin (Metaxalone)

Reported by a physician from United States on 2007-05-02

Patient: 58 year old female, weighing 128.8 kg (283.4 pounds)

Adverse reactions / side effects: Drug Toxicity, Confusional State, Drug Interaction, Troponin Increased, False Positive Laboratory Result

Adverse event resulted in: hospitalization

Suspect drug(s):
Opana ER
    Indication: Drug USE FOR Unknown Indication
    End date: 2007-04-01

Opana
    Indication: Drug USE FOR Unknown Indication
    End date: 2007-04-01

Skelaxin
    Indication: Drug USE FOR Unknown Indication
    End date: 2007-04-01

Trazodone HCL
    Indication: Drug USE FOR Unknown Indication
    End date: 2007-04-01

Vistaril
    Indication: Drug USE FOR Unknown Indication
    End date: 2007-04-01

Other drugs received by patient: Ambien; Quinine Sulfate; Sinemet; Insulin; Januvia; Amaryl; Ultram

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009